ClinicalTrials.gg
Drug

Lemborexant clinical trials

Also written E2006 and Dayvigo.

studies test it
53
open now
19
in phase 3
7
first study started
2011

How each study uses lemborexant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the lemborexant studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Dec 2019 · DAYVIGO · NDA 212028 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Lemborexant
22
Lemborexant 10 mg
10
Lemborexant 5 mg
9
Lemborexant 2.5 mg
2
Lemborexant tablets
2

Brand

Dayvigo
15

Development codes

E2006
17

Studies by the year they started

53 studies that test it; most in 2026 (9)

Studies that test lemborexant, by start year
YearStudies
20111
20122
20131
20145
20151
20163
20171
20185
20191
20202
20214
20223
20234
20246
20255
20269

By phase

A phase 1/2 study counts in both.

Phase 1
22
Phase 2
19
Phase 3
7
Phase 4
8
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 25 · Other 28

Eisai Inc. (22) · Beijing Tiantan Hospital (4) · Eisai Co., Ltd. (3) · Chulalongkorn University (2) · Virginia Commonwealth University (2) · Baylor College of Medicine (1) · Indonesia University (1) · University of California, San Francisco (1)

Often tested with

Tested in the same studies.

Zolpidem (2) · Buprenorphine, Naloxone Drug Combination (1) · Ethanol (1) · Zopiclone (1) · Eszopiclone (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 6

Studies that test lemborexant.

Studies

Open first, then newest update. How each study uses lemborexant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 53

See all 53 studies that test lemborexant →

Codes

What other systems call lemborexant · ClinicalTrials.gg INT001158

  • MeSH (NLM) C000634104lemborexantConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 0K5743G68XLEMBOREXANTConfirmed FDA, NLM, Wikidata
  • RxNorm 2272403One source FDA
  • Wikidata Q20707990lemborexantConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166424LemborexantOne source FDA
  • DrugBank DB11951One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.